Immunology and Microbiology
T Cell
100%
Myeloid
100%
Immunotherapy
100%
Leukemia Cell
100%
Histocompatibility
100%
MHC Class II
100%
Flotetuzumab
100%
Interferon Gamma
33%
Hematopoietic Cell
22%
Cell Transplantation
22%
Upregulation
22%
Downregulation
11%
Xenograft
11%
Immunoglobulin A
11%
Leukemia Antigen
11%
CD33
11%
JAK-STAT Signaling
11%
Chimeric Antigen Receptor
11%
Acute Myeloid Leukemia Cell Line
11%
CD3 Antigen
11%
Keyphrases
MHC Class II
100%
Acute Myeloid Leukemia Cells
100%
MHC Class II Expression
100%
T Cell Immunotherapy
100%
Flotetuzumab
100%
Acute Myeloid Leukemia
44%
Surface Expression
33%
Interferon-γ
33%
Relapsed or Refractory Acute Myeloid Leukemia
22%
CD123
22%
Clinical Trials
11%
Patient-derived Xenograft
11%
Adverse Events
11%
Hematopoietic Cell Transplantation
11%
Malignancy
11%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
11%
Chimeric Antigen Receptor T Cells (CAR-T)
11%
JAK-STAT Pathway
11%
Acute Myeloid Leukemia Relapse
11%
THP1
11%
Leukemia-associated Antigen
11%
Leukemia Cell Lines
11%
CD33
11%
T Cell Targeting
11%
CD3 Bispecific
11%
MHC-independent
11%
Local Release
11%
CD371
11%
Localized Release
11%